Ewing sarcoma/primitive neuroectodermal tumor of the kidney treated with chemotherapy including ifosfamide

Pediatr Int. 2016 Aug;58(8):766-9. doi: 10.1111/ped.12963. Epub 2016 Jun 21.

Abstract

Ewing sarcoma/primitive neuroectodermal tumor (ES/PNET) of the kidney is extremely rare, and is usually diagnosed after nephrectomy without neoadjuvant chemotherapy. Although ifosfamide and etoposide improve survival to a great extent in ES/PNET, the use of nephrotoxic agent, particularly ifosfamide, is a concern after nephrectomy. We describe the case of a 14-year-old female patient with abdominal mass who was diagnosed with ES/PNET of the right kidney after nephrectomy. Adjuvant chemotherapy including ifosfamide and etoposide were given. The estimated glomerular filtration rate decreased to 75% after the end of therapy. There was no evidence of recurrence 70 months after initial diagnosis.

Keywords: Ewing sarcoma; drug toxicity; ifosfamide; primitive neuroectodermal tumor; renal tumor.

Publication types

  • Case Reports

MeSH terms

  • Adolescent
  • Antineoplastic Agents, Alkylating / therapeutic use
  • Female
  • Humans
  • Ifosfamide / therapeutic use*
  • Kidney Neoplasms / diagnosis
  • Kidney Neoplasms / drug therapy*
  • Magnetic Resonance Imaging
  • Neuroectodermal Tumors, Primitive
  • Sarcoma, Ewing / diagnosis
  • Sarcoma, Ewing / drug therapy*
  • Tomography, X-Ray Computed

Substances

  • Antineoplastic Agents, Alkylating
  • Ifosfamide